Evidence map›Paper›PMID 33344501›Full record

ArticleFrontiers in molecular biosciences2020

7,3',4'-Trihydroxyisoflavone, a Metabolite of the Soy Isoflavone Daidzein, Suppresses α-Melanocyte-Stimulating Hormone-Induced Melanogenesis by Targeting Melanocortin 1 Receptor.

Ji Hye Kim, Jae-Eun Lee, Taewon Kim, Myung Hun Yeom, Jun Seong Park, Eric di Luccio, Hanyong Chen, Zigang Dong, Ki Won Lee, Nam Joo Kang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Observational
  3. Biocompatible exosomes derived fromRegenerative biomaterials · 2025
    Article
  4. GiantInternational journal of molecular medicine · 2025
    Article
  5. Review
  6. Article
  7. In Vitro Human Monoamine Oxidase Inhibition and Human Dopamine DInternational journal of molecular sciences · 2023
    Article
  8. Protective Function ofPlants (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ji Hye KimSchool of Food Science and Biotechnology, Kyungpook National University, Daegu, South Korea.
Jae-Eun LeeSchool of Food Science and Biotechnology, Kyungpook National University, Daegu, South Korea.
Taewon KimSchool of Food Science and Biotechnology, Kyungpook National University, Daegu, South Korea.
Myung Hun YeomAmorepacific Corporation R&D Center, Skin Research Institute, Yongin, South Korea.
Jun Seong ParkAmorepacific Corporation R&D Center, Skin Research Institute, Yongin, South Korea.
Eric di LuccioDepartment of Genetic Engineering, School of Life Sciences, College of Natural Sciences, Kyungpook National University, Daegu, South Korea.
Hanyong ChenThe Hormel Institute, University of Minnesota, Austin, MN, United States.
Zigang DongThe Hormel Institute, University of Minnesota, Austin, MN, United States.
Ki Won LeeWorld Class University Biomodulation Major, Department of Agricultural Biotechnology, Seoul National University, Seoul, South Korea.
Nam Joo KangSchool of Food Science and Biotechnology, Kyungpook National University, Daegu, South Korea.
Kyungpook National University · KRAmorepacific (South Korea) · KRUniversity of Minnesota · USSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

7,3',4'-Trihydroxyisoflavone (7,3',4'-THIF) is a metabolite of daidzein which is a representative isoflavone found in soybean. Recent studies suggested that 7,3',4'-THIF exerts a hypopigmentary effect in B16F10 cells, however, its underlying molecular mechanisms and specific target protein remain unknown. Here, we found that 7,3',4'-THIF, but not daidzein, inhibited α-melanocyte-stimulating hormone (MSH)-induced intracellular and extracellular melanin production in B16F10 cells by directly targeting melanocortin 1 receptor (MC1R). Western blot data showed that 7,3',4'-THIF inhibited α-MSH-induced tyrosinase, tyrosinase-related protein-1 (TYRP-1), and tyrosinase-related protein-2 (TYRP-2) expressions through the inhibition of Microphthalmia-associated transcription factor (MITF) expression and cAMP response element-binding (CREB) phosphorylation. 7,3',4'-THIF also inhibited α-MSH-induced dephosphorylation of AKT and phosphorylation of p38 and cAMP-dependent protein kinase (PKA). cAMP and Pull-down assays indicated that 7,3',4'-THIF strongly inhibited forskolin-induced intracellular cAMP production and bound MC1R directly by competing with α-MSH. Moreover, 7,3',4'-THIF inhibited α-MSH-induced intracellular melanin production in human epidermal melanocytes (HEMs). Collectively, these results demonstrate that 7,3',4'-THIF targets MC1R, resulting in the suppression of melanin production, suggesting a protective role for 7,3',4'-THIF against melanogenesis.

Indexed as

3′4′-Trihydroxyisoflavone7depigmentationmelanocortin 1 receptormelanogenesisα-MSH

Identifiers

PMID33344501
PMCPMC7747307
OpenAlexW3110001640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.